Colon Pharmaceuticals announced that the 11th meeting of the 8th board of directors of the company reviewed and approved the share repurchase plan. The company plans to use its own funds to repurchase shares through centralized bidding transactions for employee stock ownership plans or equity incentives. If they fail to use them within a specified period of time after the repurchase is completed, they will be cancelled. The repurchase capital is not less than 50 million yuan and no more than 100 million yuan, and the repurchase price does not exceed the specified limit. The repurchasable shares are expected to account for 0.09%-0.18% of the total share capital. The repurchase period is 12 months from the date the board of directors approves the plan, and the board of directors of the company authorizes management to handle related matters.

Colon Pharmaceuticals announced that the 11th meeting of the 8th board of directors of the company reviewed and approved the share repurchase plan. The company plans to use its own funds to repurchase shares through centralized bidding transactions for employee stock ownership plans or equity incentives. If they fail to use them within a specified period of time after the repurchase is completed, they will be cancelled. The repurchase capital is not less than 50 million yuan and no more than 100 million yuan, and the repurchase price does not exceed the specified limit. The repurchasable shares are expected to account for 0.09%-0.18% of the total share capital. The repurchase period is 12 months from the date the board of directors approves the plan, and the board of directors of the company authorizes management to handle related matters.